overview of the phase ii smart start trial
Published 5 years ago • 143 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
5:12
phase ii trial of acalabrutinib, lenalidomide and rituximab in patients with mcl
-
1:44
smart start for newly diagnosed dlbcl: rituximab/lenalidomide/ibrutinib
-
3:26
phase ii study of acalabrutinib, lenalidomide & rituximab for high tumor burden follicular lymphoma
-
4:18
phase ii study of naratuximab emtansine plus rituximab in dlbcl and other b-nhls
-
3:23
the phase ii ezh2 inhibitor trial
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
22:14
brian’s cancer journey with a clinical trial – part 2
-
9:35
understanding clinical trials for hodgkin lymphoma with dr. lori leslie
-
2:22
phase ib trial of acalabrutinib rituximab with or without lenalidomide in r/r follicular lymphoma
-
2:21
the swog 1608 and phase ib/ii trials for follicular lymphoma
-
3:45
update from soho 2020 on follicular lymphoma
-
1:53
relapsed follicular lymphoma: hope from a non-chemotherapy regimen of lenalidomide and obinutuzumab
-
3:13
augment: is the combination of lenalidomide & rituximab efficacious in elderly patients with inhl?
-
1:39
overview of the cllr3 trial of obinutuzumab
-
2:49
overview of classical therapies for follicular lymphoma
-
6:06
ash 2019 interview - dr jason westin - diffuse large b-cell lymphoma updates & the smart start study
-
2:17
phase 2 study of acalabrutinib-lenalidomide-rituximab in untreated mantle cell lymphoma patients
-
6:01
phase 1 lymphoma clinical trials